Total national coverage footprint for PENFS increases to roughly 100 million covered livesCARMEL, Ind., Dec. 19, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced significant new medical policy coverage from a major national health insurer for Percutaneous Electrical Nerve Field Stimulation (“PENFS”). The coverage sp ...

LONDON, Ontario, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the pricing of its underwritten U.S. public offering (the “Offering”) of 1,739,130 common shares, together with accompanying warrants to purchase 869,565 common sha ...

VEON’s Mobilink Microfinance Bank Launches Islamic Banking Operations in Pakistan A new era of digital Islamic finance Dubai and Islamabad, December 19, 2025 – VEON Ltd. (Nasdaq: VEON), a global digital operator, announced today that its financial services subsidiary, Mobilink Microfinance Bank Ltd., has launched Islamic banking operations in Pakistan, expanding access to Shariah-compliant financial services in in response to growing customer demand. Mobilink Bank inaugurated its first dedicated Islami ...

RONAN, Mont., Dec. 19, 2025 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) ("AirJoule Technologies" or "AIRJ"), a leading technology platform that unleashes the power of water from air, today announced a collaboration with the Red Dot Ranch Foundation (“Red Dot Ranch”) to bring cutting-edge off-grid water solutions to rural communities in coastal California. This positions the AirJoule™ platform technology to address critical water infrastructure gaps while demonstrating the commercial ...

– Bempedoic Acid Highlighted by ACC for LDL-C Lowering in Patients with Peripheral Artery Disease and Diabetes Based on Proven Cardiovascular and Limb Benefits – ANN ARBOR, Mich., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) welcomed the inclusion of bempedoic acid as a first-line, evidence-based therapy for LDL-C lowering for patients on maximally tolerated statins in the 2025 American College of Cardiology (ACC) Scientific Statement on Management of Peripheral Artery Disease (PAD) in Adults w ...

Smyrna, Delaware, Dec. 19, 2025 (GLOBE NEWSWIRE) -- AiRWA Inc. (Nasdaq: YYAI) (the “Company”), a technology licensing company developing a next-generation RWA-focused exchange for the trading of tokenized U.S. equities, today announced that it has entered into securities purchase agreements with investors for the purchase and sale of 15,382,378 shares of common stock at a purchase price of $1.02 per share, pursuant to a registered direct offering, resulting in gross proceeds of approximately $15.69 million, ...

New standalone mobile app applies DraftKings’ proven technology to event contracts, offering a streamlined experience and expanding the Company’s product portfolioBOSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) -- DraftKings Inc. (NASDAQ: DKNG) (“DraftKings” or the “Company”) today announced the launch of DraftKings Predictions, formally entering prediction markets under the oversight of the U.S. Commodity Futures Trading Commission (CFTC). DraftKings Predictions is a new standalone mobile app and web product that a ...

VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”), is pleased to announce the voting results from its annual general meeting of shareholders (the “Meeting”) held on December 16, 2025. All matters submitted to shareholders for approval at the Meeting were approved in accordance with management’s recommendations, including: (a) fixing the number of directors of the Company at six (6) and electing the following ind ...

$20.1 million upfront with a milestone-driven additional $20.1 million to advance INB-619, IN8bio’s novel gamma-delta (“γδ”) T cell engager through an Investigational New Drug (“IND”) application Financing led by Coastlands Capital with participation from new and existing biotechnology investors Initial proceeds extend cash runway into the first half of 2027 NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (“IN8Bio” or the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company develo ...

公司近期业绩与预期更新 - 公司将于2026年1月13日举行分析师与投资者电话会议，届时管理层将提供2025年和2026年更新后的营收指引 [1] - 此次会议源于公司近期创纪录的交易更新，以及超出市场预期的年终业绩表现，该表现确认了创纪录的12月业绩、加速的营收势头以及正的调整后EBITDA [2] - 公司首席执行官Daniel Wagner和首席财务及运营官Arthur Yao将出席电话会议 [2] 2026年营收可见性与市场共识差异 - 公司已披露其2026年已签约的营收为2.09亿美元，这一数字显著超过当前分析师对该年约1.71亿美元的共识预期 [2] - 管理层认为市场仍然严重低估了其营收的规模和可见性，并计划在电话会议上直接解决这一差异，提供关于销售渠道转化、扩张活动和未来可见性的额外背景信息 [2][3] - 管理层计划基于已签约收入、已执行的部署和快速扩张的企业销售渠道，为2025年和2026年提供明确的指引，以重置市场预期 [3] 公司业务描述 - Rezolve Ai是AI驱动解决方案的行业领导者，专注于增强客户互动、运营效率和营收增长 [4] - 其Brain Suite是世界上首个为企业级智能商务构建的企业AI平台，提供先进的工具，利用人工智能在全球范围内驱动搜索、交易、履约和个性化服务 [4] 非GAAP财务指标定义 - 公司使用某些非GAAP财务指标，如年度经常性收入、EBITDA和调整后EBITDA，以补充其合并财务报表 [8] - 年度经常性收入定义为在适用期间最后一天来自客户的合同性月度经常性收入的年化价值 [9] - EBITDA定义为经利息支出、所得税、财产和设备折旧以及收购无形资产摊销调整后的净收入（亏损） [10] - 调整后EBITDA定义为EBITDA再经未实现外汇损益、与员工、顾问及相关方相关的股权激励、衍生资产和衍生负债在每个报告期末按公允价值重估产生的损益等多项调整后的结果 [10] 2025年ARR预测数据 - 公司预测2025年12月的月度经常性收入为1749万美元 [13] - 根据ARR定义，公司预测的2025年末ARR退出率为2.0988亿美元 [13]